SCHEMBL697153

SCHEMBL697153

Cc1cccc([C@H](C)c2nccn2C(=O)OCCOC(C)C)c1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
ADRA2A P08913 4/20 0.31
ADRA2B P18089 4/20 0.31
ADRA2C P18825 4/20 0.31
ADRA1A P35348 3/20 0.31
ADRA1B P35368 3/20 0.31
ADRA1D P25100 2/20 0.31
TP53 P04637 2/20 0.31
KCNH2 Q12809 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703068 0.90 ALDH1A1 (0.33) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL697702 0.89 MAPK1 (0.43) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL699093 0.89 ALDH1A1 (0.40) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL698827 0.88 ALDH1A1 (0.35) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL698859 0.88 MEN1 (0.34) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL698041 0.88 CYP19A1 (0.36) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL697258 0.87 MAPK1 (0.38) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL3529304 0.87 GRIN2B (0.37) LMNAPOLBMAPTCYP1A2CYP3A4
SCHEMBL3525398 0.87 CHRM5 (0.36) LMNAKMT2APOLBMAPK1MEN1
SCHEMBL698638 0.87 BCHE (0.38) MAPK1ALDH1A1MAPTTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885KMT2A 945/4885POLB 3099/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885KMT2A 945/4885POLB 3099/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885KMT2A 945/4885POLB 3099/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 LMNA 3030/4885KMT2A 945/4885POLB 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.